Lisbon, Lisbon, Portugal
Prof. Dr. Thomas Danne is Chief Medical Officer International of Breakthrough T1D (formerly JDRF). He is the Director-Emeritus of the Department of General Pediatrics Endocrinology/Diabetology & Clinical Research at the “AUF DER BULT” Hospital for Children and Adolescents, Hannover Medical School, Germany, which is the largest pediatric diabetes center in Germany. He trained at the Free University Berlin Children´s Hospital in Berlin and was Consultant Pediatrician at the Charité Children´s Hospital of the Humboldt University Berlin. He is a former Research Fellow of the Joslin Diabetes Center of Harvard Medical School in Boston. Presently he is appointed as Chairman of the SWEET-registry (www.sweet-project.org) and Vice-Chairman of the INNODIA-iVZW (www.innodia.eu), a consortium to fight type 1 diabetes. He has served as Secretary-General and President of the International Society for Pediatric and Adolescent Diabetes (ISPAD) Also, he is the Past-President of the German Diabetes Association (DDG). He has been awarded the “Helmut-Otto-Medal” of the German Diabetes Association, the “Somogyi-Award” of the Hungarian Diabetes Association the ISPAD “Prize of Achievement”, the ISPAD “Prize for Innovation” with the SWEET intiative, and the “Lifetime Achievement Award” of the International Diabetes Federation (IDF). His research interests include basic and clinical research in pediatric diabetology with special emphasis on disease modifying therapies for type 1 diabetes, quality improvement through registers, new insulins, glucose sensors, insulin pumps and automated insulin delivery.
As Breakthrough T1D’s (formerly JDRF) Chief Medical Officer International, I will be supporting Breakthrough T1D‘s overall mission strategy, as well as current and future clinical and research initiatives. In this role I will help to expand our international presence and power progress toward cures for type 1 diabetes.